Achiron A, Barak Y
Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, 52621, Israel, affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Israel.
J Neurol Sci. 2006 Jun 15;245(1-2):47-51. doi: 10.1016/j.jns.2005.05.019. Epub 2006 Apr 24.
Cognitive dysfunction is among the main symptoms of multiple sclerosis (MS) and adversely affects patients' quality of life. The occurrence of cognitive impairment early in the disease process raises crucial issues related to definition of the impairment and its magnitude as well as to the tools applied to the assessment. To date there is little evidence concerning the reliability and validity of cognitive measures in early MS and their predictive long-term role. As MS is a complex disease, multidimensional approaches should be further developed and validated to study the cognitive sphere in the early stages of the disease. Considering that none of the available tests performed in isolation is able to provide a complete picture of the cognitive impairment in early MS, this calls for the definition of phase duration, impairment and tools appropriate for use by clinicians and researches. The present review proposes a framework aimed to help neurologists in approaching cognitive impairment in early MS and stimulate discussions and evaluations of the suggested recommendations.
认知功能障碍是多发性硬化症(MS)的主要症状之一,对患者的生活质量产生不利影响。在疾病进程早期出现的认知障碍引发了与障碍定义、严重程度以及评估所用工具相关的关键问题。迄今为止,关于早期MS认知测量的可靠性和有效性及其预测长期作用的证据很少。由于MS是一种复杂疾病,应进一步开发和验证多维方法,以研究疾病早期阶段的认知领域。鉴于单独进行的现有测试均无法全面呈现早期MS认知障碍的情况,这就需要明确阶段持续时间、障碍以及适合临床医生和研究人员使用的工具。本综述提出了一个框架,旨在帮助神经科医生应对早期MS的认知障碍,并激发对所提建议的讨论和评估。